NCT03613077

A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 153 (actual)
• Sponsor: Institut Straumann AG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Prospective, multi-center, non-interventional observation to document the success and survival rates of Straumann BLX Implants used for tooth replacement in cleared indications up to 1 year after implant placement

Detailed description

Objective of the study is to confirm the safety and performance of Straumann BLX Implants used for tooth replacement in cleared indications up to 12 months after implant placement. Implants used are Straumann® BLX Implant Roxolid® SLActive®. Regular Base (3.5 mm): implant diameters 3.75 and 4.5mm, in lengths 6, 8, 10, 12,14, 16 and 18 mm Wide Base (4.5 mm): diameter 5.5 mm in lengths 6, 8, 10 and 12 mm

Conditions

• Surgical Operation With Implant of Artificial Internal Device

Interventions

Type	Name	Description
PROCEDURE	surgical placement of an endosteal implant	Subjects, male or female at least 18 years old, with the need of dental implant therapy and restoration according to the cleared indications for the implant

Timeline

• Start date: 2018-05-14
• Primary completion: 2020-02-02
• Completion: 2025-08-21
• First posted: 2018-08-02
• Last updated: 2026-01-09

Locations

1 site across 1 country: Germany